The combination of topical squalamine and intravitreal ranibizumab appears to boost visual acuity more rapidly than ranibizumab alone in patients with retinal vein occlusion, a small study shows. Medscape Medical News
Pyron Award lecture focuses on optogenetics as vision restoration strategy
VIENNA — The Pyron Award lecture at the American Society of Retina Specialists meeting focused on optogenetics, an exciting advancement with the possibility of restoring vision in blind patients with inherited retinal degeneration. Gary W. Abrams, MD, explained that the concept, first described in 2005 by Boyden and colleagues, consists of the introduction of the genetic material of a light-sensitive protein into the cell membrane of light-insensitive retinal cells to effectively turn them into photoreceptors.
Valeant to acquire Amoun Pharmaceutical
Valeant Pharmaceuticals International announced in a press release that it has entered into a definitive agreement to purchase Mercury (Cayman) Holdings, the holding company of Amoun Pharmacuetical, for approximately $800 million in addition to conting…
House passes 21st Century Cures Act
By a vote of 344 to 77, the U.S. House of Representatives on July 10 passed the 21st Century Cures Act, a bipartisan bill that authorizes several changes to the approval process for drugs and medical devices.The bill, H.R. 6, also authorizes an $8.7 bi…
FDA approves iDesign Advanced WaveScan Studio System for LASIK procedures
The FDA approved the iDesign Advanced WaveScan Studio System for LASIK procedures, according to a press release from Abbott.The system generates a high-definition scan that captures more than 1,200 micro-readings of the eye and identifies the shape of the cornea, its curvature, how light passes through the eye and pupil diameter under different lighting conditions. The “blueprint” of each patient’s eye measures and maps irregularities that may affect vision, which helps to create a personalized LASIK treatment plan, the release said.
Sally Dillehay, Ed.D., OD, MS, of Visioneering Technologies, Named to Vision Monday’s 2015 Most Influential Women in Optical
ALPHARETTA, Ga.–(BUSINESS WIRE)–Sally Dillehay, Ed.D, OD, of Visioneering Technologies, Inc. (VTI), has been recognized by Vision Monday as one of the Most Influential Women in Optical for 2015, in the Executive Suite category.